The immunohistochemistry market plays a vital role in disease diagnosis and drug discovery applications. Immunohistochemistry involves the process of visually detecting antigen expressions in tissue sections by using antibodies specific to antigens. The technique allows researchers to analyze the distribution and quantity of targeted antigens in tissue slides via staining. It finds application in detecting various cancers and infectious diseases by identifying tumor markers, viral or bacterial infections. The technique aids pathologists examining tissue biopsies to determine the specific type and stage of cancer, decide which targeted therapy would likely work best for treatment.
The global immunohistochemistry market is estimated to be valued at US$ 2.88 billion in 2024 and is expected to exhibit a CAGR of 6.5% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the immunohistochemistry market are Merck KGaA, Rockland Immunochemicals Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB, Agilent Technologies Inc., Abcam plc., Becton Dickinson and Company, Miltenyi Biotec, Biocare Medical LLC, Eagle Biosciences Inc., Bio-Techne, Diagnostic Biosystems Inc., and BioGenex. Recent advancements in digital pathology and companion diagnostics offer lucrative opportunities in the immunohistochemistry market. Companies are increasingly investing in the development of digital pathology solutions integrated with artificial intelligence and machine learning algorithms for fast and accurate disease diagnosis from stained tissue slides. Technological advancements in multiplex immunohistochemistry allow detection of multiple biomarkers simultaneously, fuelling biomarker research activities.
Market drivers
One of the key drivers for the Immunohistochemistry Market Growth is the growing prevalence of cancer globally. Immunohistochemistry plays a vital role in cancer diagnosis and management by identifying specific biomarkers to determine cancer type and progression. According to the World Health Organization, cancer burden is expected to grow due to rapidly aging population and increasing adoption of cancer-causing behaviors such as smoking. Advancements in digital pathology solutions are also fueling the demand for immunohistochemistry in applications ranging from disease diagnosis to drug development. Integration of AI and automation improves workflow, turnaround time, and diagnostic accuracy.
Get more insights on Immunohistochemistry Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)